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ABSTRACT 
The purpose of this study was to determine if EEG 
technicians using collodian are exposed to diethyl 
ether and to determine if there was an accumulation 
of ether in the body after repeated exposures. Breathing 
zone air and expired-air samples were collected on four 
EEG technicians for five consecutive days. Expired-
air samples were also collected the following Monday 
morning. 
Measurable amounts of ether were found in all 
samples collected from the subjects. No relationship 
was found between the levels of ether in the breathing 
zone and levels found in the individual subject's 
expired-air. Also, levels of ether in the expired-
air did not increase over the week nor was there any 
consistent increase in levels at the end of the day 
immediately after exposure as compared to the morning 
level. The scatter diagram of the number of EEGs per-
formed and the levels of ether in the breathing zone 
indicate a positive trend between these two factors. 
It can be concluded from this study that EEG tech-
nicians are exposed to diethyl ether via collodian use. 
It can also be concluded that a body burden exists in 
EEG technicians with repeated exposure to low concen-
trations of ether. Expired-air sample results were 
considered invalid because of analytical problems. 
For this reason, no conclusions can be drawn regarding 
a relationship between exposure levels and expired-
air levels of ether, nor can any statement be made 
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CHAPTER I 
INTRODUCTION 
Collodian is a substance containing 4% dinitro-
cellulose, 24% ethyl alcohol, and 70% diethyl ether 
(Gosselin, Hodge, Smith & Gleason, 1976). It is a thick, 
colorless liquid with an ether-like odor (U.S. Coast 
Guard [Chris], 1978). It is used to adhere electro-
encephalogram electrodes to the scalp_ The solvent 
mixture of diethyl ether and ethyl alcohol is reportedly 
the chief source of toxicity in collodian (Gosselin 
et al., 1976). Collodian making is recognized as an 
occupation in which exposure to diethyl ether may occur 
(Occupational Diseases, A Guide to Their Recognition, 
Department of Health, Education and Welfare, 1977). 
However, EEG technicians using collodian are not included 
in the list of occupations with a potent I exposure 
risk to diethyl ether. 
Problem 
Diethyl ether is a chemical that has been reported 
to have biological effects on animals and humans which 
have beeri exposed to it. EEG technicians represent 
an occupation associated with a potential exposure to 
chronic low levels of diethyl ether. 
Purpose 
The purpose of this study was to determine if EEG 
technicians are indeed exposed to low doses of hyl 
ether. The study was not intended to look at the long 
term effects of such an exposure but rather to ascertain 
if the exposure exists. In addition, this study will 
determine whether a body burden exists from chronic 
exposure to ether as demonstrated by detectible levels 
of ether in the expired air; and if so, whether there 
is a correlation between exposure levels and expired 




The occupational standard of diethyl ether as 
promulgated by the Occupational Safety and Health Admini-
stration is 400 ppm (1200 mg/m 3 ) for an 8-hour time-
weighted average concentration basis. This standard 
was adopted from the recommendations of the American 
Conference of Governmental Industrial Hygienists (ACGIH) 
and was based on the prevention of nasal irritation 
and possible narcosis (NIOSH criteria, 1977). The most 
current ACGIH threshold limit value (TLV) for ethyl 
ether remains at 400 ppm or 1200 mg/m3 , with an asso-
ciated 500 ppm or 1500 mg/m3 Short-Term Exposure Limit. 
In 1974, the Hospital Engineering Cooperative Groups 
of Denmark recommended that the highest permissible 
average concentration of diethyl ether in the breathing 
3 
zone be 3 ppm or 9 mg/m (NIOSH document, 1977). They 
state that since the lowest concentration of anesthetic 
gases which offers any risk upon long-term exposure 
is unknown it is necessary to attempt to remove all 
excesses (NIOSH document, 1977). NIOSH recommended 
that occupational exposure to waste gases, including 
diethyl ether, from anesthetic procedures be controlled 
in order to minimize potential adverse effects on the 
health and safety of workers and their unborn children. 
Studies to determine these adverse effects will be dis-
cussed in depth later in this review. 
Biotransformation 
Diethyl ether [(C 2HS )2=0] is a colorless, highly 
volatile liquid with a boiling point of 3So C. It 
possesses a pungent odor and gives off an irritating 
vapor (Goodman & Gilman, 1970). Diethyl ether has 
enjoyed long clinical and industrial use; however, there 
are a number of significant gaps in our knowledge of 
this substance and little information about its elimi-
nation or metabolism is available. 
Until the late 1960s, ethyl ether was considered 
4 
to be eliminated unchanged from the body. Haggard (1924) 
studied the recovery of diethyl ether from the expired 
air of dogs. He found that an average of 87% of the 
administered amount was recovered unchanged in the 
expired air. Onchi and Asao (1961) studied the recovery 
rate of diethyl ether in human subjects using lower 
percentages of ether. Ether was administered by 
inhalation, and then expired air was collected for three 
consecutive 40-minute periods. In the first subject, 
the amount eliminated in 120 minutes was 83.9% of the 
amount absorbed in the 20 minutes of inhalation. In 
the second and third subjects, the amounts recovered 
in 120 minutes were lower, being 49.9% and 37%, re-
spectively. The two explanations offered by Onchi and 
Asao for the difference in recovery rate as compared to 
Haggard's findings included a difference in the sizes 
of dogs and human subjects and the difference in the 
concentration of the ether vapor used. 
5 
The metabolic pathways for the degradation of 
diethyl ether have not been worked out in detail. The 
cleavage of ether by the biological system was estab-
lished by Axelrod (1956) but beyond this we know little 
about the biotransformation of diethyl ether. Van Poznak 
(1974) postulated that an aldehyde intermediate is 
formed following ether cleavage. The aldehyde so formed 
may then undergo reduction to ethanol or oxidation to 
carbon dioxide or both in the Krebs cycle (see Figure 
1 ) . 
In 1978, Aune, Ranek, Bessesen and Midrland, 
measured blood-acetaldehyde concentrations in patients 
to determine if concentrations were affected by ether 
anesthesia. Findings of the study showed that a compound 
behaving like acetaldehyde in the chromatographic system 
appeared during ether anesthesia and no blood-acetalde-
hyde increase was seen in patients not receiving ether. 
This study would appear to validate the postulation 
that an aldehyde intermediate is formed following ether 
cleavage. 
H H H H 
H--C-C-O-C-C-H 
H H H H > 
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Figure 1. Biotransformation of diethyl ether. 
Van Dyke, Chenoweth and Van Poznak (1964) studied 
the fate of diethyl-1-14 C-ether in rats. The ether 
was administered by intraperitoneal injection. Four 
7 
percent of the total radioactivity injected was collected 
over a 24-hour period as 14 co2 , and during the same 
period an additional 2% was recovered as nonvolatile 
radioactivity in the urine. A portion of the admini-
stered ether was also stored in the fat and released 
slowly. As this slow release occurred, the amount of 
ether in the animal was maintained at a constant, 
although low level. 
Cohen and Hood (1969) following autoradiographic 
studies in mice observed that initially ether was uni-
formly distributed throughout the tissue slice. After 
2 hours, most of the radioactivity had disappeared but 
some was still present in liver, kidney, intestine and 
the nasal mucous membranes. When these tissue slices 
were heated to drive off volatile 14c compound, radio-
activity was still seen to be present in the liver and 
intestines. The extracts from the liver were then 
separated by thin-layer chromatography. Exposure to 
photographic film established the presence of a nonvola-
tile radioactive metabolite. Following exposure of these 
metabolites to B-glucuronidase, they performed repeat 
radiochromatography and the major metabolic factor was 
identified as a glucoronide of ether. The appearance 
of 14C02 could be explained by the breakdown of diethyl 
ether through the addition of a hydrosyl group to form 
ethyl alcohol and acetaldehyde. Additional pathways 
are required to account for the presence of other non-
volatile metabolites (Geddes, 1972). No information 
was available regarding the biological half-life of 
diethyl ether. 
In the study conducted by Onchi and Asao (1961), 
two phases of ether elimination were described. The 
first was a rapid phase followed by a phase of slow 
decrease. They found that traces of ether were detec-
table by gas-chromatography in the expired air until 
20 hours after inhalation of ether. A diagram of ether 
elimination from that study is shown in Figure 2. 
Figure 3 demonstrates yolk concentration during uptake 
and excretion of 13% ether in 3-day living embryos 
(Smith, Caub & Lehrer, 1972). 
Effects of Diethyl Ether 
Much of the data on the effects of diethyl ether 
exposure either have been obtained by studying patients 
who experienced some type of complication following 
clinical anesthesia or by evaluating the effects of 
diethyl ether as an anesthetic. These studies do give 
us information about the acute, high dose effects of 
ether on humans. Stevens, Eger, Joas, Cromwell, White 
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Figure 2. Ether elimination results. 
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Figure 3. Uptake and elimination of ether in 
chick embryos. Adapted from Smith 
et al., 1972. 
thetics including a diethyl ether on cardiorespiratory, 
renal and hepatic function using young, healthy human 
volunteers. In the ether group, blood urea nitrogen 
(BUN) decreased significantly but returned to control 
values within 7 days; potassium values increased on the 
seventh day; and bicarbonate content tended to increase 
on the first day after anesthesia and continued to 
increase further at 7 days. 
Oyama and Takazawa (1971) explored the effects 
11 
of ether during anesthesia on carbohydrate and fat meta-
bolism by measuring plasma growth hormone (HGH), insulin, 
blood glucose, free fatty acid (FFA), and cortisone, 
using 20 male patients between the ages of 22-56 years. 
The plasma HGH concentration during ether anesthesia 
showed a significant elevation 1 hour after the start 
of the operation. There was a relative decrease in 
plasma insulin level; increases in blood glucose and 
the plasma cortisol level significantly increased. 
There was no demonstrable variation of blood FFA. 
Rosenmann, Dishon, Durst and Boss (1972) reported 
that ether anesthesia causes vasoconstriction in the 
wake of which minor morphological changes ensue. Though 
ether, per se, is not considered to be hepatoxic, its 
administration is accompanied by mild hepatic functional 
derangements with or without minimal cytological evi-
dence of injury. While agreeing that ether is not a 
12 
true hepatoxin, other investigators have described alter-
ations in liver histology (i.e., reduced glycogen con-
tent, slight fatty changes, and central necrosis) 
(Adrian, 1970; Robertson, 1959). 
Epidemiologic Studies 
Several epidemiologic studies have been conducted 
in an attempt to identify the health effects associated 
with chronic exposure to waste anesthetic gases. How-
ever, none of the studies provided information on the 
anesthetic agent or on the concentrations of the gases 
present. 
NIOSH (NIOSH criteria, 1971, p. 29) reports: 
In 1966, Vaisman surveyed by questionnaire 
303 Russian anesthesiologists (193 men and 
110 women). Ninety-eight percent reported 
using diethyl ether; 59% nitrous oxide; 
28% halothane; and 21% other agents. A 
high incidence of headache, fatigue, irri-
tability, nausea, and itching was reported. 
The authors also noted that 18 of 31 
pregnancies among anesthesiologists who 
were between the ages of 24 and 38 ended 
in spontaneous abortions. In addition, 
there were two premature births and one 
child was born with a congenital malfor-
mation. The anesthesiologists with abnormal 
pregnancies had exposure of 25 hours per 
week or more while those with normal 
pregnancies did not exceed 15 hours per 
week. 
Other epidemiologic studies will not be reviewed here 
because they give us no information regarding the agents 
used. However, the study discussed above suggests that 
chronic exposure to low concentrations of anesthetic 
13 
gases, which include diethyl ether, may have deleterious 
effects on the health of workers. 
Animal Studies 
In order to determine teratogenic effects of 
diethyl ether, Smith et al. (1972) conducted studies 
on chicken embryos exposed to varying levels of ether 
during incubation. The mortality and anomaly rates 
of chick embryos after exposure to ether atmospheres 
are shown in Table 1. The types of anomalies produced 
by exposure to ether on the third and fourth day general-
ly were similar both in type and incidence (see Table 
2). However, the incidence of eye anomalies was 30.4% 
after all ether treatments. Only 8% of the anomalies 
encountered in 1,110 control eggs during this same 
period were of the eye. Defects included anophthalmia, 
and microphthalmia. This study demonstrated the 
teratogenic capability of diethyl ether in the verte-
brate, although the exact mechanism for that effect 
is not known (Smith et al., 1972). 
Stevens et al. (1975) reported the effects of 35-day 
exposures to subanesthetic concentrations of diethyl 
ether in mice, rats and guinea pigs which were in a 
phase of rapid body growth. Diethyl ether reportedly 
had a negligible effect on rat or mouse weight gain 
and a detrimental effect in guinea pigs at the one per-










































































































































































































































































































































































































































































































































































































































































































































































































































the higher dose of ether, this dose was lethal to mice 
and guinea pigs but not rats for unknown reasons. The 
mortality was unrelated to changes in blood or the 
appearance of histologic changes in any tissue examined, 
including bone marrow. These animals did manifest gross 
hepatic enlargement. Perhaps ether or its metabolism 
to ethyl alcohol stimulated growth of the liver, but 
how that is related to ether lethality is unclear. 
In another study, rabbits, rats and guinea pigs 
were exposed to 2000 ppm of diethyl ether for 7 hours 
per day, 5 days per week for a total of 7 weeks. During 
the exposures, the animals were observed for signs of 
possible toxicity, including alterations in activity, 
symptoms of eye and nasal irritation, skin condition 
and respiratory distress. The results of the study 
demonstrated no consistent increases in organ ratios, 
no hematological deviations, and no changes in SGOT 
and SGPT levels (Chenoweth, Leong, Sparschu & Torkelson, 
1972). 
In a study regarding exposure to lower concen-
trations of diethyl ether (7 hours, 5 days a week for 
6-7 weeks) using rats, rabbits and guinea pigs at 1/10 
minimum alveolar concentration (minimum alveolar con-
centration is defined as the minimum concentration in 
the alveolus at which 50% of subjects moved in response 
to skin incision [Wood & Wood, 1982]), ether was without 
reported deleterious effect and compared well with 
the air-exposed controls (Chenoweth, 1971). 
Adverse Effects from Industrial 
Use of Diethyl Ether 
As well as an inhalation anesthetic, diethyl ether 
is used as a solvent for waxes, fats, oils, perfumes, 
alkaloids, dyes, gums, resins, nitrocellulose, hydro-
17 
carbons, raw rubber and smokeless powder; a refrigerant, 
in diesel fuels, in dry cleaning, as an extractant, 
and as a chemical reagent for various organic reactions. 
Yet, despite this wide industrial use, there is prac-
tically nothing in the literature about ether as an 
industrial poison. The literature that is available 
states that industrial exposure to chronic low concen-
trations may cause a variety of symptoms including loss 
of appetite, nausea, vomiting, faintness, exhaustion, 
headache, dizziness, drowsiness, excitation, psychic 
disturbances and constipation. Albuminuria has been 
reported (Occupational diseases, 1977) as well as poly-
cythemia, increased white count, and occasionally slight 
anemia (Hamilton & Minot, 1920). Local effects of ether 
vapors are irritation to the eye, nose and throa~ and 
contact to the liquid may produce a dermatitis (Occu-
pational diseases, 1977). 
Research Questions 
The following research questions were considered 
in this investigation: 
1. Are EEG technicians exposed to diethyl ether 
via collodian use? 
1.1 What exposure levels of diethyl ether 
are in the EEG technicians work environment? 
2. Is there a body burden of diethyl ether in 
EEG technicians with exposure to low concentrations 
of diethyl ether? 
2.1 Can diethyl ether be detected in the 
expired air of EEG technicians using collodian? 
2.2 Does diethyl ether accumulate in the body 
with repeated exposure as measured by the expired air 
concentrations? 
3. Is there a relationship between the number 
of EEGs performed and the amount of diethyl ether in 
the work environment? 
4. Do detectible levels of ether in the expired 
air have a relationship to the amount of ether in the 




The design of the study was descriptive. Air 
samples were collected from the breathing zone of each 
subject at the place of work on five consecutive days. 
During the same period, expired air samples were col-
lected for each subject pre- and postwork. An expired 
air sample was also collected prior to work the following 
week. 
Population 
The study population was composed of 4 EEG techni-
cians in the Salt Lake City area. All subjects were 
contacted via telephone and questioned as to their use 
of collodian. All subjects met the following criteria: 
1. Currently working 40 hours per week as an EEG 
technician performing 2-4 electroencephalograms per 
day. 
2. Using collodian routinely in the electro-
encephalogram procedure. 
Instrumentation 
T~e following instruments were employed in this 
investigation: 
1. A questionnaire eliciting demographic infor-
mation about all subjects and their use of collodian 
(Appendix C). 
20 
2. A personal sampling pump. Each pump was cali-
brated before and after each sampling period and visually 
checked at regular intervals during the sampling period 
to maintain a flow rate of 2 liters/minute. 
3. Charcoal collection tube: a glass tube with 
both ends flame sealed containing two sections of 400/200 
mesh activated charcoal separated by a 2 mm portion 
of urethane foam. 
4. An expired air sampling device: AS-litre 
saran bag with a 2-way sealable valve. 
Sampling Method 
1. The questionnaire responses were elicited 
by the researcher. 
2. The personal sampling pump and charcoal col-
lection tube were attached to each subject at the onset 
of work. At the end of the work day, the pump and 
collection tube were removed, the charcoal tube was 
sealed and labeled. This method was repeated each day 
for 5 consecutive days. A control charcoal tube 
was opened and sealed for analysis on each of the sam-
pling days. 
3. Expired air samples were collected by filling 
the 5-litre bag with approximately 3-4 vital capacity 
21 
maneuvers. When the bag was full, the subject rebreathed 
into the bag 3-5 times allowing for an equilibrium 
between alveolar air and the expired air sample. This 
method was repeated twice daily, before and after work 
for 5 consecutive days and on the morning of the 
following Monday. 
Procedure Sequence 
One week prior to sampling: 
1. Informed consent form was signed by subjects. 
2. Demographic information was obtained from sub-
jects. 
3. The date and times for each sampling were con-
firmed with the subjects. 
Sample Collection 
1. The morning of the first sampling day, an 
expired air sample was collected from subjects before 
exposure as per the sampling method at the subject's 
workplace. 
2. After collection of the expired air sample, 
a personal pump and charcoal collection tube were 
attached to each subject. 
3. At the end of the subject's work day, the after-
noon expired air sample was collected and the charcoal 
collection tube removed and sealed. 
4. Charcoal tube and expired air samples were 
taken to the Utah Biomedical Test Laboratory at the 
end of each day. 
5. This procedure sequence was repeated for 5 
consecutive days. 
6. An additional expired air sample was collected 
the following Monday morning. 
Analysis of Samples 
Samples were analyzed by Gas Chromatography at 






Four subjects were selected who met the criter-
ia for inclusion in the study. The subjects ranged 
in age from 22-47 years. Two subjects were smokers 
and two nonsmokers. The number of years of collodian 
use ranged from 10 months to 13 years. No subject 
had any history of lung disease or any acute respir-
atory problems at the time of this study. One sub-
ject reported being on the following medications: 
Synthyroid and Megace. 
Analysis of Sample 
Both air and breath samples were analyzed by 
the Utah Biomedical Test Laboratory. Results of 
the charcoal tube samples were then converted to 
3 
mg/m . The personal sampling pumps were calli-
brated before and after each sampling period and the 
average was used in the calculations. Refer to 
Appendix E for the data used in the calculations. 
Data Analysis 
The first research question stated: 
1. Are EEG technicians exposed to diethyl ether 
via collodian use? 
1.1 What exposure levels of diethyl ether 
are in the EEG technicians work environment? 
Results of sample analysis demonstrate that EEG tech-
nicians are exposed to ether. Table 3 presents the 
levels of ether found in the EEG technic work en-
vironment. Each sample contained a detectable amount 
of ether. The levels of ether ranged from 3.3 mg/m3 
to 23.6 mg/m 3 with a mean amount of 15.78 mg/m 3 and 
a median amount of 17.09 mg/m 3 . 
Research question 2 stated: 
2. Is there a body burden of diethyl ether in 
EEG technic 
of ether? 
with exposure to low concentrations 
2.1 Can diethyl ether be detected in the 
expired air of EEG technicians using collodian? 
2.2 Does diethyl ether accumulate in the body 
with repeated exposure as measured by the expired air 
concentrations? 
All samples of expired air contained detectible levels 
24 
of diethyl ether. Levels of ether in expired air samples 
ranged from .002 mg to .38 mg. The mean amount was 




Levels of Diethyl Ether in Breathing Zone Air Mg/m 3 
Monday Tuesday Wednesday Thursday Friday 
Subject Day 1 Day 2 Day 3 Day 4 Day 5 
A 8.65 19.84 20.14 9. 1 16.58 
B 14.67 18.6 20.22 9.01 
c 20.13 17.09 23.26 23.27 23.6 
D 11.2 3.3 8.5 12.29 20.42 
26 
sample results are shown in Table 4. The levels of 
ether in expired air did not increase during the week 
and in fact were lower on the last day of the week than 
on the first. Sample results demonstrated no consistent 
increase in ether levels immediately after exposure. 
Levels of ether were lower in the afternoon immediately 
after exposure than in the morning 12 out of the 18 
combined sampling days. 
Research question 3 stated: 
3. Is there a relationship between the number 
of EEGs performed and the amount of diethyl ether in 
the work environment? 
The breathing zone ether levels and the number of EEGs 
done per day were plotted on a scatter diagram. The 
graph indicates a trend toward a positive relationship 
between these two factors (Figure 4) (correlation 
coefficient r .536; 95% confidence interval .05-.8). 
Research question 4 stated: 
4. Do detectible levels of ether in the expired 
air have a relationship to the amount of ether in the 
EEG technicians work environment? 
The environmental sample results and expired sample 
results were plotted on a scatter diagram. There is 
no indication of a trend or relationship between the 




Levels of Diethyl Ether in ired Air Samples 
Monday Tues Wednesday Thursday Friday Monday 
Day 1 Day 2 Day 3a Day 4 a Day Sa Day 6a 
Subject A 
am 0.28 0.028 0.018 N.S. 0.006 0.003 
pm 0.10 0.038 0.011 0.007 0.008 
Subject B 
am 0.38 0.014 0.020 0.007 0.005 0.006 
pm 0.12 0.030 0.013 N.S. 0.10 
Subject C 
am 0.18 0.023 0.016 0.006 0.007 N.S. 
pm 0.083 0.017 0.013 0.014 0.013 
Subject D 
am 0.11 0.044 0.020 0.007 0.009 0.002 
pm 0.093 0.032 0.017 0.009 0.008 
Note. se expired a results are included as 
reported by the laboratory. It is known that 
the amount of ether in the sample bags decreased 
over time and that analysis of these samples 
was delayed 1 to 7 days therefore these results 
are considered to be invalid. 
6 
5 











. , • • 
5 10 15 20 
Breathing Zone Level of Ether mg/m 3 
II 
II 
















o 5 10 15 





• II • 
25 
Breathing zone levels and expired air 
levels of ether. 
29 
No further statistical analysis was deemed necessary 




One conclusive finding of this study is that EEG 
technicians using collodian are exposed to diethyl ether. 
This is demonstrated by the detectible levels of ether 
found in the breathing zone air of the subjects. Based 
on the assumption that exposure during the nonsampling 
period was the same as during the sampling time, the 
levels of ether found in this study can be compared 
to the recommended standard for an 8-hour time weighted 
3 
average of 1200 mg/m. The levels of ether found in 
this study were far below this recommended standard. 
However, study levels were above those recommended by 
the Hospital Engineering Cooperative Group of Denmark 
3 for long-term exposure of 9 mg/m (NIOSH document, 1977). 
A second finding of this study was that there is 
a direct relationship between the amount of ether found 
in the breathing zone air and the number of electro-
encephalograms that were performed by the technicians 
during the sampling period. A possible explanation 
is that the more that EEGs are performed, the more collo 
dian use is required, hence increasing the amount of 
ether present in the environment. Other factors that 
would influence the amount of collodian used are the 
number of electrodes that are applied for a particular 
procedure and the amount of time needed to apply the 
electrodes such as with a cooperative patient versus 
an uncooperative one. Another factor that may affect 
32 
the amount of ether in the environment is the ventilation 
rate and room size of the EEG lab and the storage of 
used collodian. 
The third finding of this study is that there is 
a body burden of diethyl ether in EEG technicians with 
exposure to low concentrations of ether. Detectible 
levels of ether were found in all samples of expired 
air including those collected after 2 days with no ether 
exposure. However, the data in this study do not show 
an accumulation of ether in the body with repeated 
exposures as measured by the expired air concentrations. 
There was no consistent increase in expired air levels 
of ether over the 5 day period of consecutive sampling. 
Levels in the expired air were lower on the last day 
of sampling than on the first day. Also, on 12 of the 
18 combined sampling days ether levels were lower in 
the afternoon immediately after exposure than in the 
morning before exposure. The levels of ether on the 
second Monday morning after 2 days with no exposure 
were only slightly lower than on Friday afternoon. 
Possible explanations for this are: 
33 
1. The expired air sample results do not accurately 
reflect expired air levels in the subject. 
1.1 One reason for this is the loss of ether 
from the collection bag. It was found during the analy-
sis of samples that the concentration of ether in the 
sampling bags decreased over a period of time. The 
samples collected on Day 1 (Monday) were analyzed within 
a few hours of collection. The next day, analysis of 
these same samples was repeated and the ether concen-
tration was found to be approximately 30% lower than 
the results from the previous day. Samples collected 
on the following days were analyzed 1 to 7 days later--
the longest delays occurring with the samples that were 
collected on the third, fourth and fifth days and with 
the samples collected the following Monday morning. 
This loss of ether from the sampling bag over time would 
result in lower amounts of ether in the samples collected 
on the third, fourth and fifth days, as well as the 
following Monday. Several possibilities may account 
for the loss of ether over time. 
1.1.1 One possibility is the presence 
of a leak from the sampling bag values or the bag walls 
themselves. Each of the sampling bags were checked 
for air tightness prior to the onset of sampling but 
the presence of a very slow leak cannot be excluded. 
1.1.2 A second explanation may be that 
the ether interacted with the bag1s surface or with 
moisture in the sample bags which condensed on the bag 
surface causing a physical nonreactive absorption of 
the gas to the condensate. The analyst reported that 
during sample measuring there was extensive deposition 
of moisture on the inside wall of the syringes after 
withdrawing air from the sampling bags. 
The mylar sampling bag used in this study may not 
be an appropriate sampling device for diethyl ether 
and/or the collection of expired air. A study done 
on this bag used vinyl chloride monomer gas to test 
for permeability and storage stability; it showed no 
loss of VCM over a period of one week. Also, it was 
found that after cleansing the bag with compressed air, 
emptying and repeating this cycle, no detectable levels 
of VCM were found in the bags. This study collected 
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VCM from the breathing zone not from expired air (Levine, 
Hebel, Bolton & Kugel, 1975). No studies were found 
which tested the bag's reliability with expired air 
samples. Other studies regarding the collection of 
expired air samples used a glass sampling tube (Brug 
none, Perbellini, Gaffuri & Apostoli, 1980; Pasquini, 
1978: Stewart, Hake & Peterson, 1974). This instru-
ment was not available to the researcher for this study. 
The research team did not determine prior to this study 
the mylar bag's reliability and stability in terms 
of expired air samples of diethyl ether. 
1.2 Invalid expired air sample results may 
also be attributed to problems encountered in the 
analytical process. 
analysis were: 
Problems encountered during sample 
1.2.1 The use of nonairtight syringes 
to draw air from sampling bag and inject into the gas 
chromatograph injection port. The nonairtight syringes 
leaked extensively, especially when injected into the 
GC injection port. The extent this altered the results 
is not known. 
1.2.2 It was not possible to obtain 
reproducible injections. Several injections (~ 6-7) 
of the same sample were performed. The outliers were 
eliminated and the average value of median values was 
computed for reporting the results. The analyst used 
the following process to obtain samples for analysis 
from the sampling bags: The bags were shaken well, 
then 2 ml of air volume was drawn from the top side 
of the bag while lying horizontally in a 5 ml syringe 
then injected into the gas chromatograph injection 
port. 
2. The second possible explanation is that the 
ether content in expired air does not reflect the 
amount of ether exposure. As stated in the literature 
review, very little is known of the metabolism and 
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elimination of ether especially in subjects exposed 
to repeated low levels of ether. One study found that 
a portion of administered ether was stored in fat and 
released slowly. As the slow release occurs, the amount 
of ether in the animal was maintained at a constant, 
although low, level (Van Dyke et al., 1964). Although 
this phenomenon is not clearly understood, its possible 
that the individual subject maintains a fairly constant 
body level of ether despite fluctuations in the environ-
mental levels. This may also be influenced by an 
individual's metabolic and body characteristics, as 
well as lifestyle. 
These results did not demonstrate a relationship 
between levels of ether in the expired air of subjects 
and those found in the breathing zone. Possible explan-
ations for this are the same as those discussed earlier. 
The first is that the expired air sample results do 
not accurately reflect expired air levels in the subject 
and the second, the ether content in expired air does 
not reflect the amount of ether exposure. 
Recommendations for Future Research 
Since it has been determined that EEG technicians 
using collodian are exposed repeatedly to low concen-
trations of ether and a body burden of ether does exist 
from this exposure, it is recommended that EEG techni-
cians using collodian be added to the list of occupations 
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with potential ether exposure. The long-term effects 
of low concentrations of ether are not known~ therefore, 
levels in the environment should be kept as low as 
possible. This should be taken in consideration in 
the construction of EEG labs, in the engineering of 
air flow and ventilation in these areas, and in work 
practice techniques. 
Because of the invalid expired air sample results, 
no recommendations can be made regarding the accumulation 
of diethyl ether in the body with repeated exposure 
or the relationship between expired air concentrations 
and breathing zone air levels of diethyl ether. 
This study was limited by the paucity of knowledge 
regarding the sampling and analysis of ether in expired 
air as well as the biotransformation and elimination of 
ether from the body. Before replication of this type 
of study is attempted, additional data on the following 
areas would be useful: 
1. Additional studies on the reliability and 
validity of various sampling instruments to determine 
expired air levels of ether. One instrument that could 
be considered for this sampling is the charcoal sampling 
tube. Its "Limit of Detection" (LOD) as reported on the 
breathing zone air samples was .01 mg. If the first day 
of expired air sample results in this study are can 
sidered the most accurate, this LOD would be far below 
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the levels of ether in expired air. It is recommended 
that in future studies of this type, analysis of samples 
be performed within a few hours of sampling if the relia-
bility and stability of the sampling instrument cannot 
or has not been determined. 
2. Research on the metabolism and elimination 
of ether through the respiratory system to arrive at 
a reliable breath decay curve. Studies comparing the 
elimination of diethyl ether through the respiratory 
system after repeated exposures to low concentrations 
of ether and elimination of ether after isolated exposure 
to higher concentrations to determine if biotransfor-
mation and elimination is dose affected. 
3. Research on other biological monitoring methods, 
such as blood and tissue sampling. 
Future areas of research might include the longi-
tudinal study of long-term exposure to ether, at both 
high and low concentrations. Subjects with high exposure 
levels may give earlier indications of adverse effects 
and the reliability of sampling methods. Subjects with 
low exposure levels may provide information especially 
relevant to the usual hospital or clinic work setting, 
and may serve to evaluate, develop, or revise the present 
occupational standards. 
Conclusion 
A general statement can be made that EEG technicians 
who use collodian are exposed to diethyl ether. Levels 
found in this study were below the recommended TLV of 
400 ppm. However, no studies were available regarding 
the effects of long-term exposure to low concentrations 
of ether. EEG technicians who use collodian may be 
a good population to study regarding possible effects 
of long-term exposure. In terms of using expired air 
sampling to study exposure to ether, more data need 
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to be acquired. A sampling instrument needs to be 
tested for it's validity and reliability. Also, more 
information is needed regarding the metabolism and elimi 
nation of ether, the breath decay curve of ether, as 






INFORMED CONSENT FORM 
Information about "Diethyl Ether Exposure to EEG Tech-
nicians Using Collodian" study: 
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The purpose of this study is to determine if EEG 
technicians using collodian are exposed to low concen-
trations of diethyl ether and to determine if diethyl 
ether is accumulated in the body with repeated exposures. 
Levels of diethyl ether in the breathing zone air 
of EEG technicians will be determined as well as levels 
of ether in expired air. A personal sampling pump and 
charcoal collection tube will be attached to the EEG 
technician for 8 hours on 5 consecutive days. Expired 
air samples will be collected in a 5-litre bag twice 
a day, pre and postwork. Environmental monitoring and 
sample collection will be done for 5 consecutive days. 
A final expired air sample will be collected prework 
on the following Monday. All sampling instruments will 
be delivered to and collected at the subject's workplace. 
Details of this study have been discussed with 
the subject and an opportunity given to ask questions 
regarding the study and participation in this study. 
If there are any questions before or during the study, 
participants are free to contact Jeri Lockman at 
485-3995. 
The risk involved in participating in this study 
is the one-half to one hour per day of the subject's 
time. Sample collection will be done at the workplace 
and coordinated prior to the onset of the study. 
Benefits of this study will be an increased know-
ledge regarding ether levels in the environment and 
expired air from the use of collodian. 
All samples will be coded so as to insure confi-
dentiality. 
The subjects are free to withdraw from this study 
at any time without prejudice to themselves. 
Date 
APPENDIX B 
INFORMED CONSENT PROCEDURE FORM 
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Informed Consent Procedure 
1 . Each subject will be given information regarding 
the nature of this study and study objectives. 
2 • A detailed description of the sampling methods 
will be explained to the subjects. A personal sampling 
pump, charcoal collection tube and expired air sampling 
bag will be shown and a demonstration of its use given 
at this time. 
3. The sample procedure will be described. The 
exact times for sample collection will be coordinated 
with each subject so as to eliminate any interference 
with the subject's work schedule. Samples will be 
collected at the workplace to eliminate travel expense 
and time for the subjects. The amount of time involved 
will be approximately one-half to one hour per day for 
each subject. 
4. Potential benefits of this study will be dis-
cussed with each subject. Benefits include increased 
knowledge regarding collodian use and the level of 
diethyl ether in the air. 
5. Each subject will be informed of his/her right 
to withdraw from the study at any time without prejudice 
to him/herself. 
6. Each subject will be given an opportunity to 
ask questions regarding the study and any procedure 
in the study. 
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7. All samples will be coded so as to insure confi-
dential handling. Subjects may be given results of 
their individual samples upon request. 
8. An informed consent form will be signed by 




Name: Subject Code: 
Sex: Male Female Age 
History of lung disease (asthma, bronchitis) 
Smoker: Nonsmoker: 
Medications: 
Hours worked per week with collodian: 
Number of years of collodian use: 
How is collodian stored: 
Where is collodian stored: 







Expired air collection time: Sample A1 ____ Sample B1 
Personal Sampling Pump: On Off 
No. of EEGs Time of last EEG 
-----
Day 2 
Expired air collection time: Sample A2 Sample B2 
Personal Sampling Pump: On Off 
No. of EEGs Time of last EEG 
-----
Day 3 
Expired air collection time: Sample A3 Sample B3 
--
Personal Sampling Pump: On Off 
No. of EEGs Time of last EEG 
Day 4 
Expired air collection time: Sample A4 Sample B4 
Personal Sampling Pump: On Off 
No. of EEGs Time of last EEG 
Day 5 
Expired air collection time: Sample AS Sample 85 
Personal Sampling Pump: On Off 
No. of EEGs Time of last EEG 
-----
Day 6 
Expired air collection time: Sample A6 
APPENDIX E 





Time 6hr 38min 6hr 41min 5hr 44 min 6hr 31min 6hr 25min 
Sample 
Result ~.3 mg 14 mg 9.7 mg 6.9 mg 12 mg 
Flow 
Rate 1.54 1 ~m 1.76 1 pm 1.4 1 pm 1.94 1 pm 1.84 1 pm 
Subject B 
Sampling 
Time ~hr 40min 6hr 24min 6hr 25min -- 5hr 55min 
Sample 
lResult 8.8 mg 13 mg 13 mg -- 6.4 mg 
Flow 
IRate 1.5 1 2!fl 1.82 1 pm 1.67 1 pm -- 2 1 p_m 
Subject C 
Sampling! 
Time ~hr 39min 6hr 49min 7hr 20min 7hr 05min 7hr 25min 
Sample I I 
Result 113 mg 10 mg 18 mg 18 mg 21 mg 
Flow ! 
Rate 11.62 1 pm i 1.43 1 pm 1.76 1 pm 1.82 1 pm 2 1 pm 
Subject D 
Sampling I I I Time ~hr 21min 7hr 30min 7hr 45min j 7hr 56min 7hr 45min 
Sample i 1 b mg ! Result 2.7 mg 6.4 mg i 11 mg i 15 mg 
Flow I 
Rate .62 1 pm 1.82 1 pm 1.62 1 pm I 1.88 1 pm 1.58 1 pm 
APPENDIX F 
INFORMATION ON COLLODIAN 
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u.s. Coast Guard 




Cellulose nitrate solution 
Nitrocellulose solution 
Pyroxylin solution 
Thick liquid Colorless Ether-
like 
Box toe gum 
Nitrocellulose gum 
odor 
Floats on water. Flammable, 
irritating vapor is produced. 
Boiling point is around 94°F. 
Shut off ignition sources. Call fire department. 
stop discharge if possible. 
Isolate and remove discharged material. 
Notify local health and pollution control agencies. 
Fire 
FLAMMABLE. 
POISONOUS GASES MAY BE PRODUCED IN FIRE. 
Containers may explode in fire. 
Flashback along vapor trail may occur. 
Vapor may explode if ignited in an enclosed area. 
Extinguish with dry chemicals, alcohol foam, or carbon 
dioxide. 
Cool exposed containers with water. 
Exposure 
Call for medical aid. 
VAPOR 
Irritating to eyes, nose and throat. 
If inhaled will cause dizziness, difficult breathing, 
or loss of consciousness. 
Move victim to fresh air. 
If breathing has stopped, give artificial respiration. 




Effect of low concentrations on aquatic life is unknown. 
Fouling to shoreline. 
May be dangerous if it enters water intakes. 
Notify local health and wildlife officials. 
Notify operators of nearby water intakes. 
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1. Response to Discharge (See Response Methods Handbook, 
CG446-4). 
Issue warning, high flammability 
Restrict access 
Mechanical containment 
Should be removed 
Chamical and physical treatment 
2. Label 
3. Chemical Designations 
3.1 Synonyms: Cellulose nitrate solution; nitro-
cellulose solution; pyroxylin solution; box 
toe gum; nitrocellulose gum. 
3.2 Coast Guard compatability classification: 
Not applicable. 
3.3 Chemical Formula: Not pertinent. 
3.4 IMCO/United Nations Numerical Designation: 
3.2/2059.2061 3.3/2060.2062 
4. Observable Characteristics 
4.1 Physical State (as shipped); Viscous liquid. 
4.2 Color: Colorless. 
4.3 Odor: Depends on solvent used; often that 
of ether. 
5. Health Hazards 
5.1 Personal Protective Equipment: Self-contained 
breathing apparatus: rubber gloves; goggJes 
or face shield. 
5.2 Symptoms Following Exposure: High concentration 
of ether fumes may cause narcosis, loss of 
consciousness and respiratory paralysis if 
inhaled. Contact with eyes causes irritation. 
5.3 Treatment for Exposure: INHALATION: remove 
victim to fresh air; initiate artificial respir-
ation if breathing has stopped; call physician. 
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5.4 Toxicity by inhalation (Threshold Limit Value): 
400 ppm> 
5.5 Short-Term Inhalation Limits: 
able. 
Data not avail-
5.6 Toxicity by Ingestion: Grade 0: LD30 >15 g/kg. 
5.7 Late Toxicity: Data not available. 
5.8 Vapor (Gas) Irritant Characteristics: Vapors 
cause a slight smarting of the eyes or respir-
atory system if present in high concentrations. 
The effect is temporary. 
5.9 Liquid or Solid Irritant Characteristics: 
No appreciable hazard. Practically harmless 
to the skin. 
5.10 Odor Threshold: Data not available. 
6. Fire Hazards 
6.1 Flash Point: -49°F C.C. (ether) 
6.2 Flammable Limits in Air: 
solut ion) . 
6.3 Fire Extinguishing Agents: 
foam, carbon dioxide. 
1.9%-36% (ether 
Dry chemical, alcohol 
6.4 Fire Extinguishing Agents Not to be Used: 
Water may be ineffective. 
6.5 Special Hazards of Combusion Products: The 
formation of extremely toxic gases, notably 
oxides of nitrogen, hydrogen cyanide, and carbon 
monoxide is possible. 
6.6 Behavior in Fire: Highly flammable solvent 
vapors are formed. May travel a long distance 
to a source of ignition and flash back. 
6.7 Ignition Temperature: 356 ° F (ether). 
6.8 Electrical Hazard: Class I, Group C. 
6.9 Burning Rate: Data not available. 
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7. Chemical Reactivity 
7.1 Reactivity with Water: No reaction. 
7.2 Reactivity with Common Materials: No reaction. 
7.3 Stability During Transport: Stable. 
7.4 Neutralizing Agents for Acids and Caustics: 
Not pertinent. 
7.5 Polymerization: Not pertinent. 
7.6 Inhibitor of Polymerization: Not pertinent. 
8. Water Pollution 
8.1 Aquatic Toxicity: Data not available. 
8.2 Waterfowl Toxicity: Data not available. 
8.3 Biological Oxygen Demand (BOD): 
able. 
Data not avail-
8.4 Food Chain Concentration Potential: None. 
9. Selected Manufacturers 
1. Mallinckrodt Chemical Works 
Second and Mallinckrodt Streets 
St. Louis, MO 63160 
2. Polysciences , Inc. 
Paul Valley Industrial Park 
Warrington, PA 18976 
10. Shipping Information 
10.1 Grades or Purity: USP. All grades contain 
less than 60% nitrocellulose by weight. 
10.2 Storage Temperature: Ambient. 
10.3 Inert Atmosphere: No requirement. 
10.4 Venting: Pressure-vacuum/ 
11. Hazard Assessment Code (See Hazard Assessment Hand-
book, CG 446-3) A-T-U-V-W. 
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12. Hazard Classifications 
12.1 Code of Federal Regulations: Flammable liquid. 
12.2 NAS Hazard Rating for Bulk Water Transportation: 
Category Rating 
Fire. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 
Health 
Vapor Irritant .......................... 1 
Liquid or Solid Irri tant. . . . . . . . . . . . . . . . 0 
Poisons. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
Water Pollution 
Human Toxicity .......................... 0 
Aquatic Toxicity ........................ 1 
Aesthetic Effect ........................ 1 
Reactivity 
Other Chemicals......................... 1 
Water. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 
Self-Reaction. . . . . . . . . . . . . . . . . . . . . . . . . . . 0 
12.3 NFPA Hazard Classifications: 
Category Classification* 
Heal th Haz ard (Bl ue ) ............ . 
Flammability (Red) .............. . 




*First column refers to nonfire situation. 
13. Physical and Chemical Properties 
13.1 Physical State at 15°C and 1 atm: Liquid. 
13.2 Molecular Weight: Not pertinent. 
13.3 Boiling Point at 1 atm: 93°F = 34°C 
(ether solvent) 
13.4 Freezing Point: Not pertinent. 
13.5 Critical Temperature: Not pertinent. 
13.6 Critical Pressure: Not pertinent. 
13.7 Specific Gravity: 0.772 at 25°C (liquid). 




13.9 Liquid-Water Interfacial Tension: Not 
pertinent. 
13.10 Vapor (Gas) Specific Gravity: Not pertinent. 
13.11 Ratio of Specific Heats of Vapor (Gas): Not 
pertinent. 
13.12 Latent Heat of Vaporization: Not pertinent. 
13.13 Heat of Combustion: Data not available. 
13.14 Heat of Decomposition: Not pertinent. 
13.15 Heat of Solution: Not pertinent. 
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